Target intelligence / Profile preview

Human Immunodeficiency Virus type 1 Vif protein

Molecular classification
Viral protein, Accessory protein
01

Overview

The Human Immunodeficiency Virus type 1 (HIV-1) Vif protein, also known as the Viral Infectivity Factor, is an accessory protein encoded by the *vif* gene in HIV-1 and other lentiviruses. It is essential for viral replication and infectivity, particularly in physiologically relevant cell types such as CD4+ T cells and macrophages. Vif's primary function is to counteract host antiviral defense mechanisms mediated by APOBEC3 family proteins. Vif prevents APOBEC proteins from being packaged into budding virions, which would induce hypermutation of the viral genome during reverse transcription. Vif binds to these APOBEC proteins and recruits a cellular E3 ubiquitin ligase complex, leading to polyubiquitination and subsequent proteasomal degradation of APOBECs. In addition to its role against restriction factors, Vif binds directly to HIV-1 genomic RNA within infected cells and forms part of messenger ribonucleoprotein complexes that may protect viral RNA or mediate its engagement with Gag precursors during assembly. Mutations or deletions that disrupt functional Vif result in drastically reduced infectivity. Vif represents an attractive drug target, and small-molecule inhibitors have been identified that block its interaction with Elongin C or protect various APOBECs from degradation.

Other names
HIV-1 Vif proteinViral Infectivity FactorVif
02

Mechanism of action

Inhibition of Vif-Elongin C interaction; Protection of APOBECs from degradation

03

Biological functions

Inhibition of host antiviral defenseAPOBEC degradationViral infectivityRNA binding
04

Disease associations

InfectionHIV/AIDS
05

Safety considerations

Off-target effects on host proteinsDevelopment of drug resistanceSpecificity to HIV-1 subtypes

Beyond the preview

Go deeper on Human Immunodeficiency Virus type 1 Vif protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus type 1 Vif protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call